# Insilico Medicine

**Canonical:** https://apis.io/providers/insilico-medicine/  
**Website:** https://insilico.com  
**APIs profiled:** 0

Insilico Medicine is a clinical-stage biotechnology company applying generative AI and robotic automation to drug discovery and development. Its Pharma.AI software suite includes PandaOmics (target discovery from multi-omics data), Chemistry42 (generative chemistry with retrosynthesis, property prediction, and ADMET), Generative Biologics, inClinico (clinical trial outcome prediction), Science42 DORA (research assistant), Nach01, and PreciousGPT-family models for life sciences. The company runs its own therapeutic pipeline spanning oncology, fibrosis, and inflammation, with programs targeting TNIK, USP1, QPCTL, PHD, MAT2A, TEAD, ENPP1, KAT6 and others through Phase II. Insilico monetizes through Pharma.AI software licensing, partnerships with major pharmaceutical companies, and progression of its in-house assets. Pharma.AI tools are commercial SaaS products accessed via web UI; the company publishes open-source research code on GitHub (GENTRL, fcd_torch, BiAAE, DD-VAE, DORA) but does not expose a public commercial API.

## Kin Score — 4.1 / 100 (minimal)

Scored 2026-08-21 under rubric 0.12.0. Trend: flat (+0.0 from 4.1).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 2.6 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Insilico Medicine Domain Security** — TLSv1.3 · DMARC

## Tags

Drug Discovery, Biotech, Pharmaceuticals, Generative AI, Generative Chemistry, Target Discovery, Multiomics, Aging, Longevity, Clinical Trials, ADMET, Retrosynthesis, Pharma.AI, Chemistry42, PandaOmics

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/insilico-medicine/). Scores are computed from the provider's own public artifacts under a published rubric.